23-Mar-2017 - PPD is offering "on-the-job" training through a new, competency-based clinical research associate (CRA) apprenticeship program.
23-Mar-2017 - Axim Biotech has contracted an ophthalmology CRO to support upcoming product development and clinical trials for its cannabinoid-based therapeutics.
22-Mar-2017 - Alcami has launched a new customer portal and mobile application as part of its strategy to further diversify the company.
20-Mar-2017 - The strategic alliance between Metrion and Concept will provide clients with a fully integrated ion channel drug discovery service.
16-Mar-2017 - Fred Hutchinson Cancer Research Center will use Origin Sciences’ novel mucosal sampling device, OriCol, for sample collection as part of a Phase I HIV study.
16-Mar-2017 - The industry can't be slow to adopt eConsent solutions as technology has become an integral part of modern clinical trials, says CRF Health.
15-Mar-2017 - Celerion has implemented Verified Clinical Trials’ (VCT) biometric fingerprint technology to address “significant amount” of participants dual enrolling at Ph I units.
13-Mar-2017 - SRI International will advance compounds with the potential to treat persons exposed to biological, radiation, nuclear, and chemical agents – in a deal worth up to $90m.
09-Mar-2017 - SGS has signed a partnership agreement under which it will operate a dedicated clinical pharmacology unit for conducting Ph I inpatient clinical trials in Budapest, Hungary.
08-Mar-2017 - Almac Diagnostics will initiate sample profiling on current EORTC trials to further biomarker discovery and development.
08-Mar-2017 - In the absence of a CRO, the 200 patient NeoART study is relying on the UK NHS, crowdfunding and charity to trial an antimalarial generic for late stage bowel cancer.
08-Mar-2017 - Clinerion has expanded its services into countries in Eastern Europe, the Middle East and Africa (EEMEA) following appointment of a new regional head.
07-Mar-2017 - CROS NT has acquired PM Clinical Limited’s clinical division in order to offer clients a “full and broad range services,” says CCO.
07-Mar-2017 - High turnover rates among clinical research associates (CRA) continue to plague the industry – and competence and staff engagement are the "crux" of the issue, says IAOCR.
07-Mar-2017 - Richmond Pharmacology has opened up a third Phase I research centre in London Bridge, taking over the former Drug Research Unit at Guy’s teaching Hospital.
06-Mar-2017 - IAOCR is lobbying for a change to current ICH-GCP Guidelines , which would help CROs “deliver strong, reliable trials efficiently.”
06-Mar-2017 - The CRO market in Asia has “massive implications” as it continues to emerge as a preferred destination for clinical trials – a global market expected to reach $57bn by 2020.
06-Mar-2017 - The renewed contract covers a range of research related services, including monitoring therapeutic trials, prevention trials, and vaccines work, with the ultimate goal of an "AIDS-free generation."
01-Mar-2017 - The Trump administration is looking to massively reduce regulations – which could have major implications for pending guidelines that look to increase clinical trial patient safety.
01-Mar-2017 - Icon and the FDA are continuing development of new antibacterial treatments as part of a research project dating back to 2012.
01-Mar-2017 - Pharmaron has acquired a majority stake in Shin Nippon Biomedical Laboratories Clinical Pharmacology Center, continuing its strategy of becoming a full service R&D service provider.
28-Feb-2017 - The new center of excellence provides PPD clients with a team dedicated to clinical studies in rare disease and pediatric patient populations.
28-Feb-2017 - Researchers and patients have more efficient tools for sharing information on rare diseases, and as knowledge continues to spread, rare disease studies will become less rare.
28-Feb-2017 - Approximately 400 clinical trials in a rare disease condition are currently registered on ClinicalTrials.gov – on Rare Disease Day 2017, Outsourcing-Pharma.com examines the numbers.
27-Feb-2017 - Acticor Biotech has contracted QPS to manage a Phase I study of the company’s humanized Antibody Fragment, ACT017.